3rd Edition of International Heart Congress
June 05-07,2025 | Hybrid Event
Cardiovascular Pharmacology and Therapeutics
Cardiovascular pharmacology and therapeutics form the backbone of managing heart-related conditions through targeted drug development and clinical applications. Medications like beta-blockers, ACE inhibitors, and antiplatelet agents play a critical role in treating hypertension, heart failure, and coronary artery disease. Advances in this field have led to novel therapeutics, including sodium-glucose cotransporter-2 (SGLT2) inhibitors and PCSK9 inhibitors, which offer new hope for patients with complex cardiovascular conditions. Ongoing research focuses on personalized medicine, exploring how genetic factors influence drug response to optimize treatment strategies. By blending pharmacology with innovative therapies, this field aims to improve cardiovascular outcomes while minimizing side effects.
Shuping Zhong
University of Southern California, United States
Yong Xiao Wang
Albany Medical Center, United States
Yochai Birnbaum
Baylor College of Medicine, United States
Federico Benetti
Benetti Foundation, Argentina
Thomas Bernd Dschietzig
Relaxera GmbH & Co. KG, Germany
Mekhman N Mamedov
National Research Center for Preventive Medicine, Russian Federation
Narendra Kumar
HeartbeatsZ Academy, United KingdomSubmit your abstract Today
Title : Surgical fetal stem cells implantation in heart failure patients long term results at 14 years
Federico Benetti, Benetti Foundation, Argentina
Title : Exploring new biomarkers of cardiomyopathy
Shuping Zhong, University of Southern California, United States
Title : The development of human relaxin-2 for heart failure with preserved ejection fraction, HFpEF
Thomas Bernd Dschietzig, Relaxera GmbH & Co. KG, Germany
Title : Cancer and cardiovascular diseases: Common pathogenesis mechanisms and risk factors
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation
Title : Pulse field ablation for atrial fibrillation complications: What do we know yet
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : Lipoprotein (a): The hidden cardiovascular risk
Syed Raza, Awali Hospital, Bahrain